Skip to main content
Home > Week in Review > Other News

Chronological Index of : Other News

 Current Issue
  • Bicoll GmbH, Charite - Universitaetsmedizin Berlin, German Federal Ministry of Education and Research neurology news

    Bicoll GmbH, Munich, Germany Charite - Universitaetsmedizin Berlin, Berlin, Germany German Federal Ministry of Education and Research, Berlin, Germany Business: Neurology Bicoll and Charite's Horst-Goertz-Endowment …

    Published on 3/17/2014
  • Bio-Matrix Scientific gene/cell therapy, hematology, cancer news

    Bio-Matrix Scientific Group Inc. (OTCQB:BMSN; Pink:BMSN), La Mesa, Calif. Business: Gene/Cell therapy, Hematology, Cancer Bio-Matrix said that all shareholders on record as of March 18 will receive one share in …

    Published on 3/17/2014
  • Corgenix Medical Corp. diagnostic news

    Corgenix Medical Corp. (OTCBB:CONX), Broomfield, Colo. Business: Diagnostic Corgenix's board said it is exploring strategic alternatives. Inverness Advisors is advising Corgenix, which is not disclosing further details …

    Published on 3/17/2014
  • CureVac infectious news

    CureVac GmbH, Tuebingen, Germany Business: Infectious The European Commission awarded CureVac a 2 million ($2.8 million) innovation inducement prize to develop its RNActive vaccine technology. In April 2012, the EC …

    Published on 3/17/2014
  • Daiichi Sankyo infectious news

    Daiichi Sankyo Co. Ltd. (Tokyo:4568), Tokyo, Japan Business: Infectious Daiichi Sankyo informed a committee of Japan's Ministry of Health, Labor and Welfare (MHLW) that the company will not meet its goal of creating a …

    Published on 3/17/2014
  • Fred Hutchinson Cancer Research, NIH, Rockefeller University, Seattle Biomedical Research Institute, Seattle Children's Hospital, University of Washington infectious news

    Fred Hutchinson Cancer Research, Seattle, Wash. National Institutes of Health, Bethesda, Md. Rockefeller University, New York, N.Y. Seattle Biomedical Research Institute, Seattle, Wash. Seattle Children's Hospital, …

    Published on 3/17/2014
  • Genentech, Novartis, Roche ophthalmic news

    Genentech Inc., South San Francisco, Calif. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Ophthalmic Novartis declined to comment on a Reuters story that…

    Published on 3/17/2014
  • GlaxoSmithKline pharmaceuticals news

    GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Business: Pharmaceuticals GlaxoSmithKline paid Rs63.9 billion ($1 billion) to purchase 20.6 million shares of its GlaxoSmithKline Pharmaceuticals Ltd. (NSE:GLAXO; …

    Published on 3/17/2014
  • Juno Therapeutics, Novartis, St. Jude Medical, University of Pennsylvania cancer news

    Juno Therapeutics Inc., Seattle, Wash. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland St. Jude Medical Inc. (NYSE:STJ), St. Paul, Minn. University of Pennsylvania, Philadelphia, Pa. Business: Cancer A judge in the…

    Published on 3/17/2014
  • Massachusetts Life Sciences Center (MLSC) pharmaceuticals news

    Massachusetts Life Sciences Center (MLSC), Waltham, Mass. Business: Pharmaceuticals The MLSC awarded $1.1 million to four projects in the inaugural round of its International Collaborative Industry Program (ICIP). MLSC …

    Published on 3/17/2014
  • Pfizer gastrointestinal news

    Pfizer Inc. (NYSE:PFE), New York, N.Y. Business: Gastrointestinal The U.S. District Court for the Eastern District of Virginia granted summary judgment invalidating the reissue of U.S. Patent No. RE44048, which covers …

    Published on 3/17/2014
  • ReNeuron, Foundation Fighting Blindness, Schepens Eye Research Institute ophthalmic news

    ReNeuron Group plc (LSE:RENE), Guildford, U.K. Foundation Fighting Blindness, Columbia, Md. Schepens Eye Research Institute, Boston, Mass. Business: Ophthalmic ReNeuron said the foundation will support the development …

    Published on 3/17/2014
  • Takeda cardiovascular news

    Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Business: Cardiovascular Takeda appointed law firm Jones Day as a third-party investigator in response to issues raised by the media regarding the investigator …

    Published on 3/17/2014
  • Zogenix, U.S. Food and Drug Administration (FDA), U.S. Department of Health and Human Services (HHS) neurology news

    Zogenix Inc. (NASDAQ:ZGNX), San Diego, Calif. U.S. Food and Drug Administration (FDA), Silver Spring, Md. U.S. Department of Health and Human Services (HHS), Washington, D.C. Business: Neurology Sen. Joe Manchin (D-W.Va…

    Published on 3/17/2014
  • BioPorto Diagnostics, Thermo Fisher, Abbott diagnostic news

    BioPorto Diagnostics A/S (CSE:BIOPOR), Gentofte, Denmark Thermo Fisher Scientific Inc. (NYSE:TMO), Waltham, Mass. Abbott Laboratories (NYSE:ABT), Abbott Park, Ill. Business: Diagnostic BioPorto announced agreements with…

    Published on 3/10/2014
  • Cell Therapy Catapult, University of Leeds gene/cell therapy news

    Cell Therapy Catapult, London, U.K. University of Leeds, Leeds, U.K. Business: Gene/Cell therapy The Cell Therapy Catapult and the university's N8 Center for Translational Regenerative Medicine and its Medical …

    Published on 3/10/2014
  • GlaxoSmithKline pharmaceuticals news

    GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Business: Pharmaceuticals GlaxoSmithKline disclosed in its 2013 annual report that it lowered bonuses awarded in 2013 as a result of the ongoing investigation by …

    Published on 3/10/2014
  • NanoViricides infectious news

    NanoViricides Inc. (NYSE-M:NNVC), West Haven, Conn. Business: Infectious Infectious disease company NanoViricides denied a rumor from a blog post on investment news website Seeking Alpha that the company is being …

    Published on 3/10/2014
  • Novavax, U.S. Department of Health and Human Services infectious news

    Novavax Inc. (NASDAQ:NVAX), Rockville, Md. U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious Novavax and HHS's Biomedical Advanced Research and Development Authority (BARDA) extended to…

    Published on 3/10/2014
  • Olympus Corp. musculoskeletal news

    Olympus Corp. (Tokyo:7733), Tokyo, Japan Business: Musculoskeletal Olympus said it will discontinue operations for its U.S. biotechnology division, Olympus Biotech Corp., which includes a facility in Hopkinton, Mass. …

    Published on 3/10/2014
  • Ranbaxy Laboratories Inc., Daiichi Sankyo generics news

    Ranbaxy Laboratories Inc. (NSE:RANBAXY; BSE:500359), Gurgaon, India Daiichi Sankyo Co. Ltd. (Tokyo:4568), Tokyo, Japan Business: Generics Ranbaxy has temporarily suspended shipments of APIs from its facilities in Toansa…

    Published on 3/10/2014
  • Sanofi, United Nations Children's Fund (UNICEF) infectious news

    Sanofi (Euronext:SAN; NYSE:SNY), Paris, France United Nations Children's Fund (UNICEF), New York, N.Y. Business: Infectious Sanofi's Sanofi Pasteur vaccines division said UNICEF committed to purchase 285 million doses …

    Published on 3/10/2014
  • Shionogi pharmaceuticals news

    Shionogi & Co. Ltd. (Tokyo:4507), Osaka, Japan Business: Pharmaceuticals Effective April 1, Shionogi will reorganize its pharmaceutical research division to establish three new laboratories. One lab will focus on …

    Published on 3/10/2014
  • Teva, Mylan, Natco autoimmune, generics news

    Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Mylan Inc. (NASDAQ:MYL), Canonsburg, Pa. Natco Pharma Ltd. (BSE:NATCO; NSE:NATCOPHARM), Hyderabad, India Business: Autoimmune, Generics A judge in the…

    Published on 3/10/2014
  • Theravance infectious, gastrointestinal, pulmonary news

    Theravance Inc. (NASDAQ:THRX), South San Francisco, Calif. Business: Infectious, Gastrointestinal, Pulmonary Theravance said it expects to complete next quarter its separation into two publicly traded companies. One …

    Published on 3/10/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993